skip to main content
Idioma:
Refinado por: tipo de recurso: Conjunto de Dados remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Available datapackage for study 'A PHASE 3, OPEN-LABEL, RANDOMIZED PARALLEL,2-ARM,MULTI-CENTER STUDY OF TALAZOPARIB(BMN 673) VERSUS PHYSICIAN'S CHOICE IN GERMLINE BRCA MUTATION SUBJECTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST CANCER, WHO HAVE RECEIVED PRIOR CHEMOTHERAPY REGIMENS FOR METASTATIC DISEASE'
Available datapackage for study 'A PHASE 3, OPEN-LABEL, RANDOMIZED PARALLEL,2-ARM,MULTI-CENTER STUDY OF TALAZOPARIB(BMN 673) VERSUS PHYSICIAN'S CHOICE IN GERMLINE BRCA MUTATION SUBJECTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST CANCER, WHO HAVE RECEIVED PRIOR CHEMOTHERAPY REGIMENS FOR METASTATIC DISEASE'
Material Type:
Dataset 		Adicionar ao Meu Espaço

Available datapackage for study 'A PHASE 3, OPEN-LABEL, RANDOMIZED PARALLEL,2-ARM,MULTI-CENTER STUDY OF TALAZOPARIB(BMN 673) VERSUS PHYSICIAN'S CHOICE IN GERMLINE BRCA MUTATION SUBJECTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST CANCER, WHO HAVE RECEIVED PRIOR CHEMOTHERAPY REGIMENS FOR METASTATIC DISEASE'

Pfizer Inc

Vivli 2023

Sem texto completo

Citações Citado por
2
A PHASE 3, OPEN-LABEL, RANDOMIZED PARALLEL,2-ARM,MULTI-CENTER STUDY OF TALAZOPARIB(BMN 673) VERSUS PHYSICIAN'S CHOICE IN GERMLINE BRCA MUTATION SUBJECTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST CANCER, WHO HAVE RECEIVED PRIOR CHEMOTHERAPY REGIMENS FOR METASTATIC DISEASE
A PHASE 3, OPEN-LABEL, RANDOMIZED PARALLEL,2-ARM,MULTI-CENTER STUDY OF TALAZOPARIB(BMN 673) VERSUS PHYSICIAN'S CHOICE IN GERMLINE BRCA MUTATION SUBJECTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST CANCER, WHO HAVE RECEIVED PRIOR CHEMOTHERAPY REGIMENS FOR METASTATIC DISEASE
Material Type:
Dataset 		Adicionar ao Meu Espaço

A PHASE 3, OPEN-LABEL, RANDOMIZED PARALLEL,2-ARM,MULTI-CENTER STUDY OF TALAZOPARIB(BMN 673) VERSUS PHYSICIAN'S CHOICE IN GERMLINE BRCA MUTATION SUBJECTS WITH LOCALLY ADVANCED AND/OR METASTATIC BREAST CANCER, WHO HAVE RECEIVED PRIOR CHEMOTHERAPY REGIMENS FOR METASTATIC DISEASE

Pfizer Inc

Vivli 2022

Sem texto completo

Citações Citado por
3
Agilent gene expression microarray raw data for STO-3
Agilent gene expression microarray raw data for STO-3
Material Type:
Dataset 		Adicionar ao Meu Espaço

Agilent gene expression microarray raw data for STO-3

Johansson, Annelie ; Lindström, Linda

Karolinska Institutet 2022

Sem texto completo

Citações Citado por
4
Agilent gene expression microarray raw data for STO-3
Agilent gene expression microarray raw data for STO-3
Material Type:
Dataset 		Adicionar ao Meu Espaço

Agilent gene expression microarray raw data for STO-3

Johansson, Annelie ; Lindström, Linda

Karolinska Institutet 2022

Sem texto completo

Citações Citado por
5
Association of HER-2 Expression with prognosis in gastric cancer: a meta-analysis
Association of HER-2 Expression with prognosis in gastric cancer: a meta-analysis
Material Type:
Dataset 		Adicionar ao Meu Espaço

Association of HER-2 Expression with prognosis in gastric cancer: a meta-analysis

Dooley, Gordon

Centre for Reviews and Dissemination - CRD 2013

Sem texto completo

Citações Citado por
6
The role of BRCA status on the survival of patients with epithelial ovarian cancer: a systematic review of the literature with meta-analysis
The role of BRCA status on the survival of patients with epithelial ovarian cancer: a systematic review of the literature with meta-analysis
Material Type:
Dataset 		Adicionar ao Meu Espaço

The role of BRCA status on the survival of patients with epithelial ovarian cancer: a systematic review of the literature with meta-analysis

Dooley, Gordon

Centre for Reviews and Dissemination - CRD 2012

Sem texto completo

Citações Citado por
7
Association of KRAS p.G13D mutation with clinical outcomes of cetuximab treatment in patient with metastatic colorectal cancer: a systematic review and meta-analysis
Association of KRAS p.G13D mutation with clinical outcomes of cetuximab treatment in patient with metastatic colorectal cancer: a systematic review and meta-analysis
Material Type:
Dataset 		Adicionar ao Meu Espaço

Association of KRAS p.G13D mutation with clinical outcomes of cetuximab treatment in patient with metastatic colorectal cancer: a systematic review and meta-analysis

Dooley, Gordon

Centre for Reviews and Dissemination - CRD 2011

Sem texto completo

Citações Citado por
8
p16 gene promoter hypermethylation in esophageal carcinoma patients: a meta-analysis
p16 gene promoter hypermethylation in esophageal carcinoma patients: a meta-analysis
Material Type:
Dataset 		Adicionar ao Meu Espaço

p16 gene promoter hypermethylation in esophageal carcinoma patients: a meta-analysis

Dooley, Gordon

Centre for Reviews and Dissemination - CRD 2012

Sem texto completo

Citações Citado por
9
Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management
Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management
Material Type:
Dataset 		Adicionar ao Meu Espaço

Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management

Dooley, Gordon

Centre for Reviews and Dissemination - CRD 2011

Sem texto completo

Citações Citado por
10
Iron regulates MMP-9 expression in oral squamous carcinoma cell lines
Iron regulates MMP-9 expression in oral squamous carcinoma cell lines
Material Type:
Dataset 		Adicionar ao Meu Espaço

Iron regulates MMP-9 expression in oral squamous carcinoma cell lines

Ruchadaporn Kaomongkolgit

Chulalongkorn University 2007

Sem texto completo

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2007  (1)
  2. 2007Até2010  (1)
  3. 2011Até2011  (2)
  4. 2012Até2013  (3)
  5. Após 2013  (4)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.